Thank earnings thank call. on you. us today's you all for And joining
to revenue yet IRadimed once that excellent quarter another of It's again wonderful and truly report growth. earnings had
in As our revenue quarter sixth XXXX morning's ever this we was reported and revenues. consecutive QX release our top quarter record
of special dividend you seen; our have cash that per Board may I'm has very as announce Directors approved to also a today pleased share. of $X.XX
Allow the performance me financial we have to take achieved. short a into dive
diluted quarter morning's of that increase a last this $X.XX. for with quarter million, GAAP fourth XX% per share As was the release, revenue fourth earnings quarter reported fourth $XX.X year, over in
over ended our ended XX% December $XX.X prior XX, in year the the was a revenue XXXX. full-year For XXXX, million, December increase
has at in the diluted in earnings per the XX% a over XXXX. share come $X.XX full-year share, increase full-year XXXX per for GAAP
disruptions delivering dealt challenges only teams purchasing service with regulatory as from finance to of well and the this as but face it regulatory they tension. to engineering did XX% continuing to challenges not in Our and supply sales worldwide growth, the production of
extraordinarily I'm entire of these IRadimed and efforts extraordinary the pleased our team. with results
The such XXXX enter job an than exceptional we year XXXX our volume even sales shipment an this we with bookings that fantastic larger with outstripping team did started. backlog past
Customer demand continuing the into and the directions, the the MR our XXXX. problems space in for very record confident strong is earnings and in and all product revenue growth with lines competitor continuing we reported monitor of business feel
increasing XXXX. pump new of as growth to arise. backlog monitor product Additionally, reallocate in the balanced resources products the though; become an shipping us issues will a expect to for and lines, visibility both leading and as allows strong the driver supply XXXX may the provides and maneuver and us monitor sales excellent was well number well, growth line with FMD we strong
Last withdrew new quarter, we pump. it, as XXXX excuse re-file later the XXX(k) for our will refire reported previously, -- we IV year. me, it this And MR
you of in and see extraordinary. will launch new firmly believe IRadimed's in the this unfortunate this Although as lead has was of I delay pump, it, will and growth been to course, remain
deliver Though, simply again. one is we on business fire temporarily, been MR The XX% another XXXX monitor expect door has apparently may opened. have to and growth closed revenue near
either I Q&A You welcome session. regarding revenue our more FDA would any and later this in questions shall of issues of or hear details
of per XXXX and to we million weeks announced earlier, As GAAP non-GAAP $X.XX. diluted a diluted $X.XX $XX of in earnings report expect share to we million, earnings $X.XX to $XX with $X.XX revenue few to of
$X.XX with million $X.XX GAAP $X.XX $XX.X per and diluted of per to million, revenues report $XX.X $X.XX. to expect first earnings to non-GAAP share share For the quarter earnings XXXX, diluted we of of to
to over relatively call to to our Now the quarter. now results the CFO, new the review of Glenn, Jack I'd financial like turn